These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A New Induction to the Gene and Cell Therapy Hall Of Fame: Genome Editing. Sadelain M Mol Ther; 2016 Mar; 24(3):407-8. PubMed ID: 26952914 [No Abstract] [Full Text] [Related]
3. Salient Features of Endonuclease Platforms for Therapeutic Genome Editing. Certo MT; Morgan RA Mol Ther; 2016 Mar; 24(3):422-9. PubMed ID: 26796671 [TBL] [Abstract][Full Text] [Related]
4. Current Progress in Therapeutic Gene Editing for Monogenic Diseases. Prakash V; Moore M; Yáñez-Muñoz RJ Mol Ther; 2016 Mar; 24(3):465-74. PubMed ID: 26765770 [TBL] [Abstract][Full Text] [Related]
6. Designed nucleases for targeted genome editing. Lee J; Chung JH; Kim HM; Kim DW; Kim H Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767 [TBL] [Abstract][Full Text] [Related]
7. Point: Treating Human Genetic Disease One Base Pair at a Time: The Benefits of Gene Editing. Katsanis N Clin Chem; 2018 Mar; 64(3):486-488. PubMed ID: 29490998 [No Abstract] [Full Text] [Related]
8. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing. Hotta A; Yamanaka S Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033 [TBL] [Abstract][Full Text] [Related]
9. Epigenome Editing in the Brain. Bashtrykov P; Jeltsch A Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558 [TBL] [Abstract][Full Text] [Related]
10. Gene editing in T cell therapy. Zhang Y; Mu W; Wang H J Genet Genomics; 2017 Sep; 44(9):415-422. PubMed ID: 28967616 [TBL] [Abstract][Full Text] [Related]
11. Gene and cell therapy of human genetic diseases: Recent advances and future directions. Cetin B; Erendor F; Eksi YE; Sanlioglu AD; Sanlioglu S J Cell Mol Med; 2024 Sep; 28(17):e70056. PubMed ID: 39245805 [TBL] [Abstract][Full Text] [Related]
12. Genome- and Cell-Based Strategies in Therapy of Muscular Dystrophies. Saada YB; Dib C; Lipinski M; Vassetzky YS Biochemistry (Mosc); 2016 Jul; 81(7):678-90. PubMed ID: 27449614 [TBL] [Abstract][Full Text] [Related]
13. In vivo genome editing via the HITI method as a tool for gene therapy. Suzuki K; Izpisua Belmonte JC J Hum Genet; 2018 Feb; 63(2):157-164. PubMed ID: 29215090 [TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 for genome editing: progress, implications and challenges. Zhang F; Wen Y; Guo X Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067 [TBL] [Abstract][Full Text] [Related]
15. A Perspective on the State of Genome Editing. Carroll D Mol Ther; 2016 Mar; 24(3):412-3. PubMed ID: 26952917 [No Abstract] [Full Text] [Related]
16. SunnyTALEN: a second-generation TALEN system for human genome editing. Sun N; Bao Z; Xiong X; Zhao H Biotechnol Bioeng; 2014 Apr; 111(4):683-91. PubMed ID: 24255022 [TBL] [Abstract][Full Text] [Related]
17. Acceptance and Access to Gene Editing: Science and Our Obligations to Mankind. Fong Y; Hackett PB Mol Ther; 2017 Jan; 25(1):1-2. PubMed ID: 28129104 [No Abstract] [Full Text] [Related]
18. Site-Specific Genome Engineering in Human Pluripotent Stem Cells. Merkert S; Martin U Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935 [TBL] [Abstract][Full Text] [Related]
19. Ionizing radiation and genetic risks XIV. Potential research directions in the post-genome era based on knowledge of repair of radiation-induced DNA double-strand breaks in mammalian somatic cells and the origin of deletions associated with human genomic disorders. Sankaranarayanan K; Wassom JS Mutat Res; 2005 Oct; 578(1-2):333-70. PubMed ID: 16084534 [TBL] [Abstract][Full Text] [Related]
20. A genome editing primer for the hematologist. Hoban MD; Bauer DE Blood; 2016 May; 127(21):2525-35. PubMed ID: 27053532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]